[1]
|
Anders, H.J., Saxena, R., Zhao, M.H., et al. (2020) Lupus Nephritis. Nature Reviews Disease Primers, 6, Article No. 7.
https://doi.org/10.1038/s41572-019-0141-9
|
[2]
|
Leatherwood, C., Speyer, C.B., Feldman, C.H., et al. (2019) Clinical Characteristics and Renal Prognosis Associated with Interstitial Fibrosis and Tubular Atrophy (IFTA) and Vas-cular Injury in Lupus Nephritis Biopsies. Seminars in Arthritis and Rheumatism, 49, 396-404. https://doi.org/10.1016/j.semarthrit.2019.06.002
|
[3]
|
Rao, D.A., Arazi, A., Wofsy, D. and Diamond, B. (2020) Design and Application of Single-Cell RNA Sequencing to Study Kidney Immune Cells in Lupus Nephritis. Nature Re-views Nephrology, 16, 238-250.
https://doi.org/10.1038/s41581-019-0232-6
|
[4]
|
Yin, X., Kim, K., Suetsugu, H., et al. (2021) Meta-Analysis of 208370 East Asians Identifies 113 Susceptibility Loci for Systemic Lupus Erythematosus. Annals of the Rheumatic Dis-eases, 80, 632-640.
https://doi.org/10.1136/annrheumdis-2020-219209
|
[5]
|
Blazer, A., Dey, I.D., Nwaukoni, J., et al. (2021) Apolipoprotein L1 Risk Genotypes in Ghanaian Patients with Systemic Lupus Erythematosus: A Prospective Cohort Study. Lupus Science & Medicine, 8, e000460.
https://doi.org/10.1136/lupus-2020-000460
|
[6]
|
Vajgel, G., Lima, S.C., Santana, D.J.S., et al. (2020) Effect of a Single Apolipoprotein L1 Gene Nephropathy Variant on the Risk of Advanced Lupus Nephritis in Brazilians. The Jour-nal of Rheumatology, 47, 1209-1217.
https://doi.org/10.3899/jrheum.190684
|
[7]
|
Liu, W., Li, M., Wang, Z. and Wang, J.B. (2020) IFN-γ Mediates the Development of Systemic Lupus Erythematosus. BioMed Research International, 2020, Article ID: 7176515. https://doi.org/10.1155/2020/7176515
|
[8]
|
Yang, H. and Li, H. (2019) CD36 Identified by Weighted Gene Co-Expression Network Analysis as a Hub Candidate Gene in Lupus Nephritis. PeerJ, 7, e7722. https://doi.org/10.7717/peerj.7722
|
[9]
|
Lv, F., He, Y., Xu, H., et al. (2022) CD36 Aggravates Podocyte Injury by Activating NLRP3 Inflammasome and Inhibiting Autophagy in Lupus Nephritis. Cell Death & Disease, 13, Article No. 729.
https://doi.org/10.1038/s41419-022-05179-9
|
[10]
|
Raupov, R.K., Suspitsin, E.N., Imelbaev, A.I. and Kostik, M.M. (2022) Simultaneous Onset of Pediatric Systemic Lupus Erythematosus in Twin Brothers: Case Report. Frontiers in Pe-diatrics, 10, Article 929358.
https://doi.org/10.3389/fped.2022.929358
|
[11]
|
Wolf, S.J., Estadt, S.N., Theros, J., et al. (2019) Ultraviolet Light Induces Increased T Cell Activation in Lupus-Prone Mice Via Type I IFN-Dependent Inhibition of T Regulatory Cells. Journal of Autoimmunity, 103, Article 102291.
https://doi.org/10.1016/j.jaut.2019.06.002
|
[12]
|
Skopelja-Gardner, S., Tai, J., Sun, X., et al. (2021) Acute Skin Ex-posure to Ultraviolet Light Triggers Neutrophil-Mediated Kidney Inflammation. Proceedings of the National Academy of Sciences of the United States of America, 118, e2019097118. https://doi.org/10.1073/pnas.2019097118
|
[13]
|
Conte, C., Antonelli, G., Melica, M.E., et al. (2023) Role of Sex Hormones in Prevalent Kidney Diseases. International Journal of Molecular Sciences, 24, Article 8244. https://doi.org/10.3390/ijms24098244
|
[14]
|
Hill, B.G., Hodge, B. and Misischia, R. (2020) Lupus Nephritis in a Transgender Woman on Cross-Sex Hormone Therapy: A Case for the Role of Oestrogen in Systemic Lupus Erythematosus. Lupus, 29, 1807-1810.
https://doi.org/10.1177/0961203320946372
|
[15]
|
Edwards, M.R., Dai, R., Heid, B., et al. (2020) Low-Dose 17α-Ethinyl Estradiol (EE) Exposure Exacerbates Lupus Renal Disease and Modulates Immune Responses to TLR7/9 Agonists in Genetically Autoimmune-Prone Mice. Scientific Reports, 10, Article No. 5210. https://doi.org/10.1038/s41598-020-62124-6
|
[16]
|
Arnaud, L., Mertz, P., Gavand, P.E., et al. (2019) Drug-Induced Systemic Lupus: Revisiting the Ever-Changing Spectrum of the Disease Using the WHO Pharmacovigilance Database. Annals of the Rheumatic Diseases, 78, 504-508.
https://doi.org/10.1136/annrheumdis-2018-214598
|
[17]
|
Illescas-Montes, R., Corona-Castro, C.C., Melgui-zo-Rodríguez, L., et al. (2019) Infectious Processes and Systemic Lupus Erythematosus. Immunology, 158, 153-160. https://doi.org/10.1111/imm.13103
|
[18]
|
Singh, D., Oudit, O., Hajtovic, S., et al. (2021) Antibodies to an Epstein Barr Virus Protein That Cross-React with dsDNA Have Pathogenic Potential. Molecular Immunology, 132, 41-52. https://doi.org/10.1016/j.molimm.2021.01.013
|
[19]
|
Mok, C.C., Chu, C.S. and Tse, S.M. (2023) De Novo Lupus Nephritis after SARS-CoV-2 Infection. Lupus, 32, 893-899. https://doi.org/10.1177/09612033231175280
|
[20]
|
Soni, C., Perez, O.A., Voss, W.N., et al. (2020) Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA. Immunity, 52, 1022-1038.E7.
https://doi.org/10.1016/j.immuni.2020.04.015
|
[21]
|
Wolf, S.J., Theros, J., Reed, T.J., et al. (2018) TLR7-Mediated Lupus Nephritis Is Independent of Type I IFN Signaling. Journal of Immunology, 201, 393-405. https://doi.org/10.4049/jimmunol.1701588
|
[22]
|
Masum, M.A., Ichii, O., Yha, E.L., et al. (2019) Induced Expres-sion of Toll-Like Receptor 9 in Peritubular Capillary Endothelium Correlates with the Progression of Tubulointerstitial Lesions in Autoimmune Disease-Prone Mice. Lupus, 28, 324-333. https://doi.org/10.1177/0961203319828518
|
[23]
|
Yavuz, S., Bianchi, M., Kozyrev, S., et al. (2021) Toll-Like Re-ceptors Revisited; A Possible Role for TLR1 in Lupus Nephritis. Annals of the Rheumatic Diseases, 80, 404-406. https://doi.org/10.1136/annrheumdis-2020-218373
|
[24]
|
Alduraibi, F., Fatima, H., Hamilton, J.A., et al. (2022) Lupus Nephritis Correlates with B Cell Interferon-β, Anti-Smith, and Anti-DNA: A Retrospective Study. Arthritis Re-search & Therapy, 24, Article No. 87.
https://doi.org/10.1186/s13075-022-02766-1
|
[25]
|
Aschman, T., Schaffer, S., Biniaris Georgallis, S.I., et al. (2021) Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus. International Journal of Mo-lecular Sciences, 22, Article 11747.
https://doi.org/10.3390/ijms222111747
|
[26]
|
Goel, R.R., Wang, X., O’neil, L.J., et al. (2020) Interferon Lambda Promotes Immune Dysregulation and Tissue Inflammation in TLR7-Induced Lupus. Proceedings of the National Acade-my of Sciences of the United States of America, 117, 5409-5419. https://doi.org/10.1073/pnas.1916897117
|
[27]
|
Birmingham, D.J. and Hebert, L.A. (2015) The Complement System in Lupus Nephritis. Seminars in Nephrology, 35, 444-454. https://doi.org/10.1016/j.semnephrol.2015.08.006
|
[28]
|
Radanova, M., Vasilev, V., Mihaylova, G., et al. (2022) Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis. International Journal of Molecular Sciences, 23, Article 9281. https://doi.org/10.3390/ijms23169281
|
[29]
|
Rossi, G.M., Maggiore, U., Peyronel, F., et al. (2022) Persistent Iso-lated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis. Kidney Interna-tional Reports, 7, 2647-2656.
https://doi.org/10.1016/j.ekir.2022.09.012
|
[30]
|
Chen, K., Deng, Y., Shang, S., et al. (2022) Complement Factor B Inhibitor LNP023 Improves Lupus Nephritis in MRL/lpr Mice. Biomedicine & Pharmacotherapy, 153, Article ID: 113433.
https://doi.org/10.1016/j.biopha.2022.113433
|
[31]
|
Thiam, H.R., Wong, S.L., Wagner, D.D., et al. (2020) Cellular Mechanisms of NETosis. Annual Review of Cell and Developmental Biology, 36, 191-218. https://doi.org/10.1146/annurev-cellbio-020520-111016
|
[32]
|
Bruschi, M., Bonanni, A., Petretto, A., et al. (2020) Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis. The Journal of Rheumatology, 47, 377-386.
https://doi.org/10.3899/jrheum.181232
|
[33]
|
Wigerblad, G. and Kaplan, M.J. (2023) Neutrophil Extracellular Traps in Systemic Autoimmune and Autoinflammatory Diseases. Nature Reviews Immunology, 23, 274-288. https://doi.org/10.1038/s41577-022-00787-0
|
[34]
|
Mistry, P., Nakabo, S., O’neil, L., et al. (2019) Transcriptomic, Epigenetic, and Functional Analyses Implicate Neutrophil Diversity in the Pathogenesis of Systemic Lupus Erythemato-sus. Proceedings of the National Academy of Sciences of the United States of America, 116, 25222-25228. https://doi.org/10.1073/pnas.1908576116
|
[35]
|
Deng, Y., Zheng, Y., Li, D., et al. (2021) Expression Characteristics of Interferon-Stimulated Genes and Possible Regulatory Mechanisms in Lupus Patients Using Transcriptomics Analyses. EBioMedicine, 70, Article ID: 103477.
https://doi.org/10.1016/j.ebiom.2021.103477
|
[36]
|
Boussiotis, V.A. (2016) Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway. The New England Journal of Medicine, 375, 1767-1778. https://doi.org/10.1056/NEJMra1514296
|
[37]
|
Zhai, Y., Dong, S., Li, H., et al. (2022) Antibody-Mediated Deple-tion of Programmed Death 1-Positive (PD-1+) Cells. Journal of Controlled Release, 349, 425-433. https://doi.org/10.1016/j.jconrel.2022.07.010
|
[38]
|
Patsoukis, N., Wang, Q., Strauss, L. and Boussiotis, V.A. (2020) Revisiting the PD-1 Pathway. Science Advances, 6, eabd2712. https://doi.org/10.1126/sciadv.abd2712
|
[39]
|
Du, Y., Nie, L., Xu, L., et al. (2020) Serum Levels of Soluble Pro-grammed Death-1 (sPD-1) and Soluble Programmed Death Ligand 1 (sPD-L1) in Systemic Lupus Erythematosus: As-sociation with Activity and Severity. Scandinavian Journal of Immunology, 92, e12884. https://doi.org/10.1111/sji.12884
|
[40]
|
Hirahara, S., Katsumata, Y., Kawasumi, H., et al. (2020) Serum Levels of Soluble Programmed Cell Death Protein 1 and Soluble Programmed Cell Death Protein Ligand 2 Are Increased in Sys-temic Lupus Erythematosus and Associated with the Disease Activity. Lupus, 29, 686-696. https://doi.org/10.1177/0961203320916517
|